Capital Fund Management (CFM)
RMD icon

Capital Fund Management (CFM)’s ResMed RMD Stock Holding History

Capital Fund Management (CFM)’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,500
Closed -$3.15M – 2618
2025
Q3 		$3.15M Buy
+11,500
New +$3.14M 0.01% 1536
2024
Q2 		– Sell
-18,600
Closed -$3.68M – 2125
2024
Q1 		$3.68M Sell
18,600
-71,600
-79% -$13.1M 0.01% 1187
2023
Q4 		$15.5M Buy
90,200
+56,900
+171% +$8.74M 0.04% 563
2023
Q3 		$4.92M Buy
+33,300
New +$6.02M 0.02% 935
2020
Q2 		– Sell
-1,800
Closed -$265K – 1478
2020
Q1 		$265K Sell
1,800
-23,300
-93% -$3.71M ﹤0.01% 1285
2019
Q4 		$3.89M Sell
25,100
-40,700
-62% -$5.87M 0.03% 623
2019
Q3 		$8.89M Buy
+65,800
New +$8.62M 0.08% 318

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Capital Fund Management (CFM)'s RMD Position: Q3 2025 in Review

Capital Fund Management (CFM) sold out of ResMed (RMD) in Q3 2025, closing a stake of 33,559 shares — an estimated $9.17M sold.

Capital Fund Management (CFM) first reported a position in RMD in Q2 2013 and held it in 23 quarters. The position peaked at $14.7M in Q2 2023. 949 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Capital Fund Management (CFM) reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 33,559 ResMed shares in Q3 2025, an estimated $9.17M.
  • Capital Fund Management (CFM) first reported a position in ResMed in Q2 2013 and held it in 23 quarters.
  • Capital Fund Management (CFM)'s ResMed position peaked at $14.7M in Q2 2023.
  • 949 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2025, filed 13 Nov 2025.